At Drugwatch, we are passionate about our mission to keep people safe from the potential risks of prescription drugs and medical devices. Our team of expert writers and outreach coordinators work together to deliver trusted, up-to-date information and spread awareness about problematic medicines and devices that affect people’s health.
Combined, Drugwatch’s expert writers have decades of experience in research and investigation. They have worked for respected newspapers, magazines, universities and law firms. Drugwatch’s writers get the facts directly from trusted, credible sources, such as doctors, lawyers, medical journals, court documents and government reports. They then translate the information into language you can understand. They also develop relationships with experts, advocacy groups and patients to add first-hand knowledge and additional expertise to the information found on Drugwatch.com. Our writers and researchers are available to help journalists and editors in need of reliable research, sources and quotes.
“I love being a part of a team that works to safeguard the public and gives a voice to people harmed by the negligence of corporations.”
Part of Drugwatch’s mission is to spread awareness about the risks of prescription drugs and medical devices. The outreach coordinators connect with medical organizations and communities and alert them about risky medical products that could hurt people. They accomplish this by developing relationships and providing free resources and information tailored to each organization’s audience.
Bradley Welch manages Drugwatch’s social media and is an advocate for those affected by harmful drugs and defective medical devices. Bradley graduated from Rollins College in Winter Park with a degree in Critical Media and Cultural Studies in 2011. Bradley was part of the JUMP (Join Us in Making Progress) Active Community Program at Rollins, and has carried on this passion to help others. He has vast experience in marketing and communications within the eHealth field. He joined the Drugwatch Outreach Team in 2017.